Table 1 Patient split of training, validation, and test sets on NCCN risk groups.
Risk group | Training | Validation | Test |
|---|---|---|---|
Metastatic | 31 | 8 | 9 |
High | 13 | 5 | 6 |
Intermidate | 7 | 4 | 2 |
Unknown | 1 | 1 | 1 |
In total | 52 | 18 | 18 |
Risk group | Training | Validation | Test |
|---|---|---|---|
Metastatic | 31 | 8 | 9 |
High | 13 | 5 | 6 |
Intermidate | 7 | 4 | 2 |
Unknown | 1 | 1 | 1 |
In total | 52 | 18 | 18 |